Skip to content

Baromètre Santé Adulte 2021-2022

Baromètre Santé Adulte 2021-2022 in People Aged 18 to 64 in New Caledonia Using the WHO STEPwise Approach

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05218304
Enrollment
5471
Registered
2022-02-01
Start date
2021-07-26
Completion date
2022-05-30
Last updated
2022-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chikungunya, Chronic Disease, Dengue Fever, Diabetes, Hypercholesterolemia, Malaria, Renal Failure, Ross River, SARS-CoV Infection, Zika

Keywords

Chronic disease, Diabetes, WHO STEP approach, Prevalence, New Caledonia

Brief summary

In 2021-2022, Agence Sanitaire et Sociale Nouvelle Calédonie (ASSNC) is undertaking the Baromètre Santé Adulte for the third time. This study is carried out this year in collaboration with WHO and Institut Pasteur de Nouvelle Calédonie (IPNC). The main objective of this investigation is to describe the current levels of chronic disease risk factors in the adult population of New Caledonia aged from 18 to 64 years old. This study will also help to estimate prevalence of certain diseases (diabetes, hypercholesterolemia, renal failure), seroprevalence of arboviruses (dengue fever, Zika, chikungunya and Ross River) malaria as well as the seroprevalence of SARS-CoV-2. Repeated regularly, these surveys allow the ASS-NC to capitalize on population indicators, to compare them according to socio-demographic characteristics, to identify groups at risk, to provide changes in health behaviors and to strengthen analytical capacities in order to adapt the guidelines for public policies and prevention programs.

Detailed description

The Barometre Santé Adulte is an observational, descriptive and cross-sectional study whose data collection will take place in New Caledonia. For this study the sampling is based on the 2019 population census, according to a 3-stage stratified sample design. In total, the main sample will consist of approximately 5,500 people (first phase) and the sub-sample will consist of 1,800 people (second phase). The participation rate is estimated at 60%. Data collection will take place from February to May at the people's place drawn according to two steps: * Firstly, investigators will carry out a questionnaire with the people who gave their informed consent as well as taking physical measurements: height, weight, abdominal circumference and blood pressure. In addition to the socio-demographic characteristics of the respondents, the questionnaire deals with several health topics: consumption of psychoactive substances, diet, physical activity, health status and access to care, screening, oral health, driving motor vehicle risk, sexual health, mental health, etc. The time taken to complete the questionnaire is estimated at one hour. * Secondly, and for a sub-sample of 1,800 people, nurses will come back to the people's places who volunteer to take a venous blood test: blood sugar, total cholesterol, HbA1c, serum creatinine, CBC and serology of diseases transmitted by mosquitoes (dengue, chikungunya, Zika and Ross River, malaria). All the data collected will be entered on a tablet in the eSTEPS application. The analysis of data (R Studio software) and the drafting of the report will be carried out by ASSNC staff. The first results are expected for the second half of 2022.

Interventions

BIOLOGICALBlood sample

A questionnaire, physical measurements (height, weight, perimeter abdominal and blood pressure) for all arm will be done, approximately 5400 people carried out by investigators. Only 1800 will undergo blood samples carried out by nurses

Sponsors

Institut Pasteur
CollaboratorINDUSTRY
Pacific Community
CollaboratorOTHER
World Health Organization
CollaboratorOTHER
Institut de la Statitique et des Etudes Economiques Nouvelle Calédonie
CollaboratorUNKNOWN
Agence Sanitaire et Sociale de Nouvelle Calédonie
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

This is an observational, descriptive and cross-sectional study

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

* Individuals informed of the conduct of the research and having given their written consent to participate in the study (questionnaire and taking physical measurements); * Individuals between the ages of 18 and 64; * Individuals residing in New Caledonia in so-called ordinary housing under their main residence at the last population census in 2019;

Exclusion criteria

* Pregnant or breastfeeding women; * Tourists and transients staying in New Caledonia for less than 6 months at the time of the investigation; * People who are not intellectually fit to answer the questionnaire; * Persons subject to guardianship, curatorship or any other legal incapacity; * For the second phase of the study will be excluded people describing a febrile syndrome;

Design outcomes

Primary

MeasureTime frameDescription
To know the prevalence of the main risk factors chronic diseases (obesity, diabetes, high blood pressure, high cholesterol and kidney failure) in the adult population of New Caledonia aged 18 to 64 using the WHO STEPS survey method.Within a year after recruiting the participantIn order to measure the prevalence of the main risk factors chronic diseases, WHO STEPS method will be used. This questionnaire is a 3 steps method, the first steps is a questionnaire mainly based on medical history and health behaviors. The second steps is associated with taking physical measurements such as weight, height, blood pressure, waist size. The last steps concerned only the experimental group the sub-sample for which some blood sample will be drawn out for the detection of elevated levels of blood glucose, HbA1c, total cholesterol and serum creatinine.

Secondary

MeasureTime frameDescription
Health behaviors of the target population using the first step of the WHO STEPS survey method.Within a year after recruiting the participantTo correlate health data and everyday behaviors of the target population in order to show a trend in causal effect, in order to have specific health indicators up to date
To calculate the cardiovascular risk of the New Caledonian population using the SCORE projetWithin a year after recruiting the participantTo calculate the cardiovascular risk based on systolic blood pressure, sex, smoking status and cholesterol level.
Seroprevalence of infectious diseasesWithin a year after recruiting the participantTo Determine the seroprevalence of dengue, Zika, chikungunya and Ross River arboviruses in New Caledonia, the seroprevalence against the malaria agent as well as the seroprevalence of SARS-CoV-2.

Countries

New Caledonia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026